As the present study has confirmed the significant correlation of a new proliferation marker, the CPCC, with RFS, further studies on chromatin CKAP2 as a possible prognostic or predictive marker in the management of breast cancer are warranted. Here, CKAP2 is linked to breast carcinoma.